top of page
Companies in the News
Millendo Therapeutics Announces Initiation of Phase 2b Clinical Trial of Nevanimibe in Patients with
ANN ARBOR, Mich., September 13, 2018 – Millendo Therapeutics, Inc., a clinicalstage biopharmaceutical company focused on developing novel...
Sep 13, 2018


2018 Indigo Wheat™ Harvest Data Demonstrates Significant Yield and Quality Improvements Across more
Leveraging satellite technology, Indigo releases data on an unprecedented 40,000+ acres from the 2018 commercial wheat harvest Indigo...
Sep 13, 2018
bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Th
CAMBRIDGE, Mass. & EMERYVILLE, Calif.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) and Gritstone Oncology, Inc. today announced a...
Aug 23, 2018
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Compan
Transaction to Advance Millendo’s Compelling Pipeline of Late-Stage Programs for Orphan Endocrine Diseases Including Prader-Willi...
Aug 10, 2018
Omniome Completes $60 Million Series B Financing To Advance Novel Genomic Sequencing Technology
SAN DIEGO, July 30, 2018 /PRNewswire/ -- Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has...
Jul 30, 2018
eFFECTOR Initiates Dosing of eFT508 (tomivosertib) in a Phase 2 Add-on (CPI-A) Trial in Combination
SAN DIEGO, July 27, 2018 — eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the...
Jul 27, 2018
Gossamer Bio Announces $230 Million Series B Financing
Co-Founder & current Chief Operating Officer Sheila Gujrathi, M.D., appointed Chief Executive Officer Co-Founder & current Chief...
Jul 23, 2018


Indigo Wheat™ Demonstrates Continuous Improvement with Significant Yield Gains in Second Commercial
Indigo Wheat™ demonstrated average yield gains of 19% in low yielding conditions and 13% across all conditions Improving upon last year’s...
Jul 10, 2018
Aerpio Announces Exclusive License Agreement with Gossamer Bio for AKB-4924, a First in Class Hypoxi
CINCINNATI & SAN DIEGO--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO), today announced an exclusive global license agreement...
Jun 25, 2018
bottom of page